Abstract:Objective To observe the changes of inflammatory factors in acute lung injury (ALI) in mice induced by lipopolysaccharide (LPS), and to explore the influence of different doses of LPS on ALI onset and progress at different time points. Methods Intratracheally, LPS at the dosages of 2.5, 5.0, 7.5 and 10.0 mg/kg were administered to a total of 210 C57BL/6 mice, and according to the difference in dosage, they were divided into four groups. The ALI model was replicated by intratracheally dropping of LPS. And a normal control group and a normal saline control group were established (each, n=10). The changes of index of pathological lung tissue and lung tissue wet/dry (W/D) ratio were observed at 1, 2, 4, and 8 hours after injury, and simultaneously, the levels of norepinephrine (NE), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and protein in serum and bronchoalveolar lavage fluid (BALF) were detected. Results ①The degree of lung injury induced by LPS was dose-and time-dependent.②With the increase of LPS dosage and prolongation of time, in LPS group, the lung W/D ratio and the index of pathological lung tissue were increased;additionally, the levels of NE, TNF-α, IL-6 and protein in serum or BALF were also significantly increased. The critical occurrence point of acute respiratory distress syndrome (ARDS) with specific characteristics was at 5.0 mg/kg of LPS acting for 4 hours [lung W/D ratio: 4.97±0.41, index of pathological changes of lung tissue (score): 5.60±1.52; serum NE (ng/L): 379.99±27.65, TNF-α (ng/L): 159.15±20.62, IL-6 (ng/L): 177.15±29.13;BALF NE (mg/kg):105.85±13.66, TNF-α(mg/kg):227.22±48.01, IL-6 (mg/kg):251.55±54.08, total protein (g/L):1.59±0.37]. The injury induced by LPS acting for 8 hours in the dosage group 10.0 mg/kg was the most significant in comparisons with other groups of dosages at the same time points [lung W/D ratio:5.10±0.18 vs. 5.01±0.43, 5.01±0.19, 4.91±0.30; index of pathological changes of lung tissue (score): 9.20±1.48 vs. 8.00±1.00, 6.00±1.22, 4.40±0.89;serum NE (ng/L): 447.43±34.63 vs. 419.23±30.62, 391.16±54.91, 372.59±51.52; TNF-α(ng/L): 205.99±31.31 vs. 181.01±25.11, 161.01±13.98, 138.83±28.95; IL-6 (ng/L): 233.76±34.84 vs. 206.21±26.68, 186.58±26.54, 156.99±28.83;BALF NE (mg/kg):190.82±41.75 vs. 153.30±35.42, 122.64±25.15, 80.23±13.69;TNF-α(mg/kg):305.24±72.99 vs. 292.77±38.07, 249.60±35.20, 193.63±10.83; IL-6 (mg/kg): 354.81±67.79 vs. 303.02±54.24, 272.43±32.34, 197.64±12.35;total protein (g/L):2.31±0.30 vs. 2.02±0.26, 1.62±0.19, 1.10±0.24, P<0.05 or P<0.01]. Conclusions The severity of ALI induced by LPS in mice was positively correlated to LPS dosage and duration of its action. After administration of LPS 5 mg/kg for 4 hours, remarkable characteristic manifestations of ARDS occur in mice, reaching the critical point.

Variation of Lipopolysaccharide-Induced Acute Lung Injury in Eight Strains of Mice.

Varying Susceptibility of Pulmonary Cytokine Production to Lipopolysaccharide in Mice.

Time‑dependent changes in NLRP3 and Nrf2 levels in lipopolysaccharide‑induced acute lung injury

Effect of adenylate cyclase antagonists andagonist in acute lung injury induced by lipopolysaccharide

An evaluation of effects on induction of acute lung injury in mice by different doses of lipopolysaccharide and different durations

Study on the Building Conditions of Acute Lung Injury in Mice

Haplotype association mapping of acute lung injury in mice implicates activin a receptor, type 1.

[A mouse model of acute lung inflammation induced by lipopolysaccharide inhalation].

Expression Pattern Changes of Microrna in the Lung Tissue of Mice with Acute Lung Injury Induced by Lipopolysaccharide

Establishing a Mouse Model of Acute Lung Injury and Pulmonary Fibrosis by Intermittent Lipopolysaccharide Intraperitoneal Injection

Lipopolysaccharide-Induced Acute Lung Injury Is Associated with Increased Ran-Binding Protein in Microtubule-Organizing Center (RanBPM) Molecule Expression and Mitochondria-Mediated Apoptosis Signaling Pathway in a Mouse Model

Study on the Use of Improved Endotracheal Intubation to Instill Lipopolysaccharide for the Preparation of Mouse Acute Lung Injury Model

Microarray Profiling of Lung Long Non-Coding RNAs and Mrnas in Lipopolysaccharide-Induced Acute Lung Injury Mouse Model.

Effect of Allicin on Mice with Acute Lung Injury Induced by Lipopolysaccharide

Establishment of Acute Lung Injury Model Induced by Intraperitoneal Injection of Lipopolysaccharide in Rats

Establishment of Mouse Model of Acute Lung Injury with Exposed and Non-Exposed Intratracheal Instillations and Effectiveness Comparison

Comparative Study of Trans‐Oral and Trans‐Tracheal Intratracheal Instillations in a Murine Model of Acute Lung Injury

Potential mechanism and key genes involved in mechanical ventilation and lipopolysaccharide‐induced acute lung injury

[Changes and Role Evaluation of TNF-α and IL-1β in Lung Tissues of ARDS Mice].

Dynamic alterations in the lung microbiota in a rat model of lipopolysaccharide-induced acute lung injury

Noninvasive Intratracheal Lipopolysaccharide Instillation in Mice